Varex Imaging (VREX) to Release Earnings on Thursday

Varex Imaging (NASDAQ:VREX) is expected to issue its Q2 2025 quarterly earnings data before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of $0.14 per share and revenue of $206.76 million for the quarter. Varex Imaging has set its Q2 2025 guidance at 0.050-0.200 EPS.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Thursday, February 6th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Stock Performance

Shares of Varex Imaging stock opened at $7.60 on Thursday. The company has a 50 day moving average of $10.99 and a 200-day moving average of $12.99. The company has a market cap of $313.12 million, a PE ratio of -6.50 and a beta of 0.65. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. Varex Imaging has a 1-year low of $6.97 and a 1-year high of $17.46.

Insider Activity

In other news, SVP Kimberley E. Honeysett sold 4,007 shares of Varex Imaging stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now owns 4,002 shares in the company, valued at approximately $51,265.62. The trade was a 50.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the completion of the sale, the chief executive officer now owns 190,193 shares of the company’s stock, valued at $2,137,769.32. The trade was a 4.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. StockNews.com raised Varex Imaging from a “hold” rating to a “buy” rating in a report on Friday, February 7th. Oppenheimer reduced their price objective on Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a research note on Friday, February 7th. Finally, B. Riley reissued a “buy” rating and set a $22.00 target price (up previously from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.